Raymond James analyst Laura Prendergast added Revolution Medicines to the firm’s Analyst Current Favorites list. The list contains the current favorite stock ideas from the firm’s equity analysts. An analyst may only have one “buy” idea on the list at any given time.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD:
- Revolution Medicines Appoints Frank Clyburn to Expanded Board
- Revolution Medicines reiterates 2024 GAAP net loss guidance
- Revolution Medicines reports Q2 EPS (81c), consensus (77c)
- Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
- Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024